Spinal Muscular Atrophy Treatment Market 2020 Global Covid-19 Impact Analysis on Healthcare Sector And Business With Forecast To 2026 is latest Report published by Fortune Business Insights. This report also studies the global Spinal Muscular Atrophy Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The global spinal muscular atrophy treatment market size stood at USD 1.72 billion in 2018 and is projected to reach USD 14.49 billion by 2026, exhibiting a CAGR of 28.9% during the forecast period.
Get Sample Copy of Global Spinal Muscular Atrophy Treatment Market Report
Some of the companies operating the industry are:
- Biogen
- Novartis AG
- Genentech, Inc./ F. Hoffmann-La Roche Ltd
- Astellas Pharma Inc.
- Genzyme Corporation.
Spinal Muscular Atrophy Treatment Market Analysis From 2020 To 2026:
SMA treatment market in North America was valued at USD 854.0 million in 2018. Early approvals for SMA treatment products in the U.S., coupled with adequate reimbursement, has led to growing number of patients being treated in 2018. Europe is expected to hold the second leading position in this market by witnessing strong growth in long-term period. As per our market research study, Asia Pacific is expected to witness relatively significant growth in terms of spinal muscular atrophy treatment market value.
Global Spinal Muscular Atrophy Treatment Market 2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Spinal Muscular Atrophy Treatment Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. Regionally, this report categorizes the production, apparent consumption, export and import of Spinal Muscular Atrophy Treatment in North America, Europe, China, Japan, Southeast Asia and India.
Funding by public and private players to improve the accessibility of high-cost treatment options is likely to augment the expansion of the market during the forecast period. For instance, in the key regions of Asia such as Japan and Hong Kong have granted the status of reimbursed access to all patients, while in China, the process of reimbursement approval is currently underway. Such a positive reimbursement scenario for spinal muscular atrophy treatment is projected to boost the expansion of the market in Asia Pacific during the forecast period.
The increasing incidence and awareness for spinal muscular atrophy have increased remarkably which is propelling the demand for efficient therapeutic options leading to better patient outcomes. In recent times, there have been two substantial and very significant product launches in gene therapy for the treatment of spinal muscular atrophy. Spinal muscular atrophy was a rare disorder for a very long time which had no treatment options which often proved fatal to the infants and children suffering from the disorders. Two product launches: Spinraza (Nusinersen) by Biogen and Zolgensma (Onasemnogene abeparvovec) by Novartis for the treatment of the disorder are anticipated to drive the market greatly. Coupled with high efficiency of the therapeutics, these factors are anticipated to drive market.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations travel bans and quarantines restaurants closed all indoor events restricted over forty countries state of emergency declared massive slowing of the IT Spending market volatility falling business confidence, growing panic among the population, and uncertainty about future.
Global Spinal Muscular Atrophy Treatment Market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Spinal Muscular Atrophy Treatment market report is provided for the international markets as well as development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report additionally states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
What is the scope of the report?
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
Which market dynamics affect the business?
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Regional Market Overview:
This report focuses on Spinal Muscular Atrophy Treatment Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2024, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
Competitive Analysis:
The Spinal Muscular Atrophy Treatment Market Size, Share, Growth report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.
Key Stakeholders
- Raw material suppliers
- Distributors/traders/wholesalers/suppliers
- Regulatory bodies, including government agencies and NGO
- Commercial research and development (RandD) institutions
- Importers and exporters
- Government organizations, research organizations, and consulting firms
- Trade associations and industry bodies
- End-use industries
Table Of Content:
1 Market Overview
1.1 Spinal Muscular Atrophy Treatment Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
3 Global Spinal Muscular Atrophy Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Spinal Muscular Atrophy Treatment Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Spinal Muscular Atrophy Treatment Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Spinal Muscular Atrophy Treatment Manufacturer Market Share in 2018
3.3.2 Top 6 Spinal Muscular Atrophy Treatment Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Spinal Muscular Atrophy Treatment Market Analysis by Regions
4.1 Global Spinal Muscular Atrophy Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Spinal Muscular Atrophy Treatment Sales and Market Share by Regions (2014-2019)
4.1.2 Global Spinal Muscular Atrophy Treatment Revenue and Market Share by Regions (2014-2019)
4.2 North America Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
4.3 Europe Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
4.5 South America Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
5 North America Spinal Muscular Atrophy Treatment by Country
5.1 North America Spinal Muscular Atrophy Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Spinal Muscular Atrophy Treatment Sales and Market Share by Country (2014-2019)
5.1.2 North America Spinal Muscular Atrophy Treatment Revenue and Market Share by Country (2014-2019)
5.2 United States Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
5.3 Canada Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
5.4 Mexico Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
8 South America Spinal Muscular Atrophy Treatment by Country
8.1 South America Spinal Muscular Atrophy Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Spinal Muscular Atrophy Treatment Sales and Market Share by Country (2014-2019)
8.1.2 South America Spinal Muscular Atrophy Treatment Revenue and Market Share by Country (2014-2019)
8.2 Brazil Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
8.3 Argentina Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
8.4 Colombia Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
9 Middle East and Africa Spinal Muscular Atrophy Treatment by Countries
9.1 Middle East and Africa Spinal Muscular Atrophy Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Spinal Muscular Atrophy Treatment Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Spinal Muscular Atrophy Treatment Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
9.3 Turkey Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
9.4 Egypt Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
9.5 Nigeria Spinal Muscular Atrophy Treatment Sales and Growth Rate (2014-2019)
10 Spinal Muscular Atrophy Treatment Market In Developing Conutries
11 South America Spinal Muscular Atrophy Treatment Market Analysis by Countries
12 Competitive Landscape
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Spinal Muscular Atrophy Treatment Market Forecast
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
Continued…
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245